Invenomic Capital Management’s Eastman Chemical EMN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$4.52M	Sell	59,243 -217,980	-79%	-$15.7M	0.21%	109
2025 Q4	$17.7M	Buy	277,223 +145,533	+111%	+$8.97M	0.85%	44
2025 Q3	$8.3M	Buy	131,690 +71,794	+120%	+$5.01M	0.43%	81
2025 Q2	$4.47M	Buy	59,896 +32,768	+121%	+$2.57M	0.25%	104
2025 Q1	$2.39M	Sell	27,128 -7,660	-22%	-$723K	0.12%	148
2024 Q4	$3.18M	Sell	34,788 -9,562	-22%	-$981K	0.18%	131
2024 Q3	$4.96M	Sell	44,350 -138,873	-76%	-$13.9M	0.27%	100
2024 Q2	$18M	Buy	183,223 +3,813	+2%	+$378K	0.94%	39
2024 Q1	$18M	Buy	179,410 +53,143	+42%	+$4.67M	0.96%	37
2023 Q4	$11.3M	Sell	126,267 -27,175	-18%	-$2.17M	0.6%	67
2023 Q3	$11.8M	Sell	153,442 -5,278	-3%	-$438K	0.49%	62
2023 Q2	$13.3M	Sell	158,720 -13,536	-8%	-$1.1M	0.74%	48
2023 Q1	$14.5M	Buy	172,256 +78,750	+84%	+$6.76M	0.83%	40
2022 Q4	$7.62M	Buy	93,506 +38,737	+71%	+$3.12M	0.55%	65
2022 Q3	$3.89M	Buy	+54,769	New	+$4.92M	0.34%	89
2020 Q4	–	Sell	-8,862	Closed	-$692K	–	152
2020 Q3	$692K	Sell	8,862 -24,165	-73%	-$1.82M	0.5%	78
2020 Q2	$2.3M	Sell	33,027 -4,514	-12%	-$284K	1.71%	11
2020 Q1	$1.75M	Sell	37,541 -31,485	-46%	-$2.02M	1.47%	20
2019 Q4	$5.47M	Buy	+69,026	New	+$5.31M	2.21%	8